A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, March 31, 2023.
Novo Nordisk's blockbuster weight loss injection Wegovy could prevent up to 1.5 million heart attacks, strokes and other cardiovascular events in the U.S. over 10 years, according to a study released this week.
Researchers from the University of California, Irvine, also found that Wegovy could result in 43 million fewer Americans with obesity over a decade.
An estimated 83 million Americans without established cardiovascular disease would also experience heart health benefits after taking Wegovy for a decade.
Wegovy would reduce the risk of serious heart problems in that population by 17.8%, which translates to 1.5 million preventable heart attacks, strokes and other cardiovascular events.
Persons:
Novo, Wegovy, Nathan Wong, Ozempic
Organizations:
University of California, Novo Nordisk, UC, Wall Street, Disease, Nordisk's, Nordisk
Locations:
Chicago , Illinois, U.S, Irvine, Danish, UC Irvine's